Stocksigma LogoStocksigma Logo

Medicamen Organics Schedules Board Meeting to Approve H1 FY27 Results

Medicamen Organics Limited announced that its Board of Directors will meet on 14th Nov'26 to consider and approve the standalone and consolidated unaudited

Medicamen Organics Schedules Board Meeting to Approve H1 FY27 Results

Medicamen Organics Ltd 路 Intimation 路 14 Nov 2026, 5:30 am

Medicamen Organics Schedules Board Meeting to Approve H1 FY27 Results Medicamen Organics Limited announced that its Board of Directors will meet on 14th Nov'26 to consider and approve the standalone and consolidated unaudited financial results, along with the Statement of Assets and Liabilities and Statement of Cash Flows, for the half year ended 30th Sep'26. Additionally, the trading window for dealing in company securities, closed since 1st Oct'26 for designated persons and their immediate relatives, will remain closed until 48 hours post the declaration of results.

Original exchange filing (PDF)

More announcements from Medicamen Organics Ltd

All Medicamen Organics Ltd announcements